TNFα antagonists in rheumatoid arthritis patients seen in everyday practice

被引：15
|
作者：
Falgarone, Geraldine [1 ]
Duclos, Muriel [2 ]
Boissier, Marie-Christophe [2 ]
机构：
[1] Hop Avicenne, Serv Rhumatol, CHU Avicenne, F-93009 Bobigny, France
[2] Univ Paris 13, INSERM ER118, Avicenne Teaching Hosp, Rheumatol Dept,AP HP, Bobigny, France
来源：
JOINT BONE SPINE | 2007年 / 74卷 / 06期
关键词：
TNF alpha antagonists; real-world practice; everyday practice; rheumatoid arthritis;
D O I：
10.1016/j.jbspin.2007.10.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：523 / 526
页数：4
相关论文
共 50 条
  • [31] Rheumatoid arthritis in 2005:: which patients should receive TNFα antagonists and when?: A point of view
    Le Loët, X
    Lequerré, T
    Vittecoq, O
    JOINT BONE SPINE, 2005, 72 (06) : 447 - 450
  • [32] Mortality from cardiovascular causes is reduced in rheumatoid arthritis patients treated with TNF antagonists.
    Gomez-Reino, J.
    Perez-Pampin, Eva
    Descalzo, Miguel A.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S245 - S245
  • [33] Heart failure among younger rheumatoid arthritis and Crohns patients exposed to TNF-α antagonists
    Curtis, J. R.
    Kramer, J. M.
    Martin, C.
    Saag, K. G.
    Patkar, N.
    Shatin, D.
    Burgess, M.
    Xie, A.
    Braun, M. M.
    RHEUMATOLOGY, 2007, 46 (11) : 1688 - 1693
  • [34] TNF-antagonists improve arterial stiffness in patients with rheumatoid arthritis: a meta-analysis
    Gravos, A.
    Vlachopoulos, C.
    Georgiopoulos, G.
    Pietri, P.
    Terentes-Printzios, D.
    Georgakopoulos, C.
    Stamatelopoulos, K.
    Tousoulis, D.
    EUROPEAN HEART JOURNAL, 2016, 37 : 105 - 106
  • [35] ACTIVE THERAPEUTIC IMMUNIZATION WITH TNF-KINOID IN RHEUMATOID ARTHRITIS PATIENTS WITH SECONDARY RESISTANCE TO TNFα ANTAGONISTS IS SAFE AND IMMUNOGENIC
    Durez, P.
    Miranda, P.
    Toncheva, A.
    Berman, A.
    Rillo, O. L.
    Boutsen, Y.
    Kehler, T.
    Mociran, E.
    Soto Saez, L.
    Fautrel, B.
    Mariette, X.
    Sokalov, P.
    Lucero, E.
    Vlak, T.
    Grazio, S.
    Mastrovic, K.
    Chirieac, R.
    Grouard-Vogel, G.
    Dhellin, O.
    Ouary, S.
    Fanget, B.
    Vandepapeliere, P.
    Boissier, M-C
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 362 - 362
  • [36] The use of TNF antagonists in rheumatic diseases other than rheumatoid arthritis
    Cohen, MD
    BULLETIN ON THE RHEUMATIC DISEASES, 2002, 51 (12) : 1 - 7
  • [37] TNF-α Antagonists and Other Recombinant Proteins for the Treatment of Rheumatoid Arthritis
    Brasington, Richard
    JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 2009, 34A (02): : 349 - 350
  • [38] Cost-effectiveness analyses of TNF antagonists in rheumatoid arthritis: A review
    Bansback, N
    Regier, D
    Ara, R
    Brenan, A
    Shojania, K
    Esdaile, J
    Anis, A
    Marra, C
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S510 - S510
  • [39] DOES SERUM DRUG LEVEL CORRELATES WITH ULTRASOUND EVALUATION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TNF ANTAGONISTS?
    Opris, D.
    Borangiu, A.
    Gudu, T.
    Mazilu, D.
    Balanescu, A.
    Saulescu, I.
    Ionescu, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 702 - 703
  • [40] Mortality rate is reduced in rheumatoid arthritis patients treated with TNF antagonists. Data from biobadaser
    Gomez-Reino, J. J.
    Carmona, L.
    Pampin, E. Perez
    Descalzo, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 318 - 318
12345